
BioHarvest Sciences (BHST) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.15 | $-0.14 | -7.14 % |
| Q2 | Aug 11, 2026 | $-0.17 | $-0.12 | -41.7 % |
| Q1 | May 14, 2026 | $-0.11 | $-0.12 | 8.33 % |
| Q4 | Mar 31, 2026 | $-0.10 | $-0.10 | 0.00 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $7.87M | $9.37M | -16.1 % |
| Q2 | Aug 11, 2026 | $8.84M | $9.54M | -7.34 % |
| Q1 | May 14, 2026 | $8.50M | $8.80M | -3.37 % |
| Q4 | Mar 31, 2026 | $9.10M | $9.28M | -1.93 % |
BioHarvest Sciences (BHST) publicó su última previsión de noviembre 12, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de $32M - $33.5M para el período.
En comparación con la previsión anterior, BioHarvest Sciences reducido redujo su previsión de ingresos desde un rango anterior de $37M - $40M.
BioHarvest Sciences ha emitido 5 actualizaciones de orientación entre el noviembre 13, 2025 y el noviembre 12, 2026. During this period, the company raised its outlook 1 time and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.12 | $-0.12 | $-0.10 |
| Actual | $-0.15 | $-0.17 | $-0.11 | $-0.10 |
| Surprise | -7.14% | -41.7% | +8.33% | 0.00% |
| Revenue | ||||
| Estimate | $9.4M | $9.5M | $8.8M | $9.3M |
| Actual | $7.9M | $8.8M | $8.5M | $9.1M |
| Surprise | -16.1% | -7.34% | -3.37% | -1.93% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.14 | $-0.15 | $-0.04 |
| Revenue | ||||
| Consensus | $8.1M | $9.4M | — | — |